@article{oai:repo.qst.go.jp:00047609,
 author = {Karube, Masataka and Yamamoto, Naoyoshi and Nakajima, Mio and Yamashita, Hideomi and Nakagawa, Keiichi and Miyamoto, Tadaaki and Tsuji, Hiroshi and Fujisawa, Takehiko and Kamada, Tadashi and 軽部 雅崇 and 山本 直敬 and 中嶋 美緒 and 中川 恵一 and 宮本 忠昭 and 辻 比呂志 and 藤澤 武彦 and 鎌田 正},
 issue = {1},
 journal = {International journal of radiation oncology, biology, physics},
 month = {May},
 note = {In an aging society, many senior citizens want less invasive treatment because of potential medical complications. The National Institute of Radiological Sciences has started to treat stage I lung cancer with single-fraction carbon-ion radiation therapy (CIRT) as a dose escalation prospective phase 1/2 trial. We evaluated the efficacy and safety of CIRT for patients 80 years of age and older, undergoing single-fraction CIRT.},
 title = {Single-Fraction Carbon-Ion Radiation Therapy for Patients 80 Years of Age and Older With Stage I Non-Small Cell Lung Cancer.},
 volume = {95},
 year = {2016}
}